Merlin (MRLN) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
22 May, 2026Company overview and business model
Develops autonomous flight technology for fixed-wing aircraft, with Merlin Pilot system enabling reduced-crew or uncrewed operations.
Business model combines hardware integration, recurring high-margin software support, and ancillary services.
Initial focus on military sector with plans to expand into civilian markets over the next fifteen years.
Holds a $105 million IDIQ contract with USSOCOM and has a $3 billion pipeline of opportunities.
Nearly 100 engineers and over 160 employees, with expertise in autonomy and certified software for military and civilian applications.
Financial performance and metrics
2025 revenue: $7.55 million (up from $1.23 million in 2024); net loss: $74.78 million (2024: $55.25 million).
Cost of revenue in 2025: $9.18 million; R&D expenses: $32.48 million; G&A: $20.09 million.
Adjusted EBITDA for 2025: $(47.98) million.
Cash and cash equivalents at year-end 2025: $59.3 million; net cash used in operations: $59.87 million.
Accumulated deficit as of December 31, 2025: $551.1 million.
Use of proceeds and capital allocation
No proceeds from resale by selling securityholders; proceeds from Series A Warrant exercises (if any) to be used for general corporate purposes, including capex, acquisitions, and growth opportunities.
No specific uses designated for warrant proceeds; no current agreements for acquisitions or strategic transactions.
Latest events from Merlin
- SPAC raising $250M to target tech sectors, offering redemption rights but with dilution risks.MRLN
Registration filing22 May 2026 - $250M SPAC IPO targets tech-driven sectors, offering redemption rights but with dilution risks.MRLN
Registration filing22 May 2026 - SPAC targets TMT sectors with $250M IPO, but public shareholders face dilution and execution risks.MRLN
Registration filing22 May 2026 - $250M IPO targets tech-driven sectors, with sponsor/insider control and potential dilution for public shareholders.MRLN
Registration filing22 May 2026 - Secondary sale of 13.3M shares by a major investor; no IPO proceeds to company; high growth, high risk.MRLN
Registration filing22 May 2026 - $250M raised, $1.52M net income, no target yet; must complete a deal by Nov 2026.MRLN
Q4 202422 May 2026 - $250 million IPO completed; all proceeds in trust pending a business combination.MRLN
Q3 202422 May 2026 - 2025 net income reached $6.0M; business combination with Merlin Labs set for March 2026.MRLN
Q4 202522 May 2026 - Revenue up 15.4% year-over-year, net loss widened, and liquidity rose to $183M post-financing.MRLN
Q1 202622 May 2026